HugoScore hugoscore.org

Patient care navigation and health copilot AI

Neatly Health

Neatly supports patient-selected records and sharing. Optional identifiable sharing must be distinguished from population insights. The review corrects blanket sharing claims and outdated caregiver-feature descriptions, while keeping source and correction gaps explicit.

Document-based draft Read full report Open directory

Checklist assessment dated October 30, 2026. Independent confirmation is incomplete. Hugo has not personally verified this service.

Mixed7 of 12 agency checks metDocument-based draft. Independent confirmation incomplete; not product-tested.How categories work

Agency checklist · October 30, 2026

Mixed 7 of 12 yes

Document-based draft. Independent confirmation is incomplete. Hugo has not personally verified this service.

Assessed function: Patient-initiated recording, summaries and health questions, with separate cohort-insight commercialization and optional third-party opportunities.

A no can mean missing documentation or institution-dependent control; it does not by itself establish harmful behavior. These categories are not clinical safety or product-quality ratings.

  • Public documents do not establish actual product behavior.
  • The independent review screened rules and selected evidence; it did not replicate all twelve answers for this tool.
See all twelve answers and their evidence
QuestionAnswerEvidence / reviewSource and reasoning
1. Told it is AIYesdocumented
Not independently replicated
neatly provides an AI-powered health companion to help you understand your care. Source

Terms section 2. Privacy section 7 describes what 'Our AI' does.

2. Operator and model maker namedNonot-documented
Not independently replicated
We use trusted service providers for hosting, AI processing, and analytics. Source

Neatly Health, Inc. is named. No AI model maker is named in the Privacy Policy, Terms, FAQ, About or App Store listing.

3. Patient chooses to use itYesdocumented
Not independently replicated
Conversation recordings (doctor-patient visits you choose to record). Source

Patient downloads and starts recording. Optional third-party 'opportunities' are opt-in.

4. Patient sets the taskYesdocumented
Not independently replicated
Yes! Chat with Neatly any time about your health for neutral guidance and support. Source

Patient chooses recordings and questions. Operator has its own aims (cohort insights, optional trial recruitment, premium specialists), but these are not documented as steering the patient's task.

5. Patient can decline or stopYesdocumented
Not independently replicated
Conversation recordings (doctor-patient visits you choose to record). Source

Self-started: Q3 is yes and no care depends on using Neatly. Source is the Q3 source. Terms 11: 'You may stop using the service anytime.'

6. Patient sees the AI outputYesdocumented
Not independently replicated
Within minutes, you'll get a plain-language summary of what was discussed Source

App Store listing: 'Read the full transcript whenever you want'.

7. Patient can correct or challengeYesdocumented
Not independently replicated
If you find mistakes in the transcription or notes, contact us for help. Source

Privacy section 7. Contact is a chat widget or message form. No self-serve edit is documented.

8. Patient can get a copyNonot-documented
Not independently replicated
To make a request to access, delete, correct, or opt out, contact us at: Source

An 'access' request is mentioned for state-law rights, but no export, download or copy is documented. Sharing summaries with caregivers is described as a feature.

9. Patient can deleteYesdocumented
Not independently replicated
If you want something deleted, just ask us and we'll remove it within 30 days. Source

Closing the account deletes everything within 90 days.

10. Training or sale does not override patient choiceNodocumented
Not independently replicated
Use your data in de-identified or aggregated form for research and commercial purposes. Source

Terms section 4 license. No opt-out is offered for de-identified or aggregated use. FAQ says Neatly sells population insights to pharma. Training is not addressed. Identifiable sharing is opt-in only.

11. Patient can run it or take it elsewhereNonot-documented
Not independently replicated
Quotation not recorded; evidence repair pending. Source

Vendor-hosted. No self-hosting or documented move-elsewhere route.

12. No advertising or data businessNodocumented
Not independently replicated
We sell aggregated, de-identified insights to pharmaceutical and medical device companies. Source

FAQ: 'We make money by selling population-based insights to pharmaceutical companies and other research organizations'. Marketing says individual data is never sold, which is consistent with the Terms. Optional opportunities may also share identifiable data with pharma or CROs with consent.

Initial coding: Claude Sonnet helpers, compiled by Claude Opus 5.5 (Anthropic). Selective review and corrections: GPT-6 Astra (OpenAI). Editor: Hugo Campos. Acceptance of corrections is not product verification.

Checklist rules · Independent review and limitations · Later evidence follow-up

Earlier v1.3 assessment and control finding

Historical assessment under different rules. It does not set the current checklist zone.

Leans expandsEarlier review, before the published method. Documents only.

Agency finding, before method v1.3

Potentially agency-expanding, with data-commercialization caveat

Legacy editorial placement, pre-method: 82

This profile has not yet been reviewed under the published method. Its finding and any number are editorial placements made before the method existed.

Evidence
Documentary review. Public sources only, no hands-on testing by HugoScore.
Review status
AI draft. No person has settled the findings.
The question we ask Who does Neatly Health serve in this deployment?
Control Patient-initiated recording, summaries and health questions, with separate cohort-insight commercialization and optional third-party opportunities.
Agency read Mixed
Vendor
Neatly Health, Inc.
Who it serves
Patient-directed visit recording and health companion AI
Primary User
Patients, caregivers, families, and people managing complex or chronic care
Control Model
Vendor-hosted public service. Controls and downstream processors depend on the assessed deployment.
Patient Impact
A retained visit account can support questions and challenge misunderstandings. Cohort patterns are not necessarily comparable treatment evidence, and per-answer source links remain unverified.
Profile Status
Document-based draft
Last assessed
Oct 30, 2026
Earlier review confidence
Moderate for public product and policy descriptions (AI-assisted draft)
Earlier review model
OpenAI Codex / GPT-6
Earlier human review record
Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.

Earlier evidence and assessment

The sections below preserve the earlier review. Its classifications and provenance are historical; the checklist above gives the current draft classification.

Earlier finding · Legacy editorial placement, pre-method: 82

Method v1.3. The control line is evidence for how the agency finding arose, not a quality score. Legacy editorial placement, pre-method: 82. Not comparable with v1.3 positions.

Potentially agency-expanding, with data-commercialization caveat

Neatly supports patient-selected records and sharing. Optional identifiable sharing must be distinguished from population insights. The review corrects blanket sharing claims and outdated caregiver-feature descriptions, while keeping source and correction gaps explicit.

Patient agency

How this tool changes agency

Expands agency when

A retained visit account can support questions and challenge misunderstandings. Cohort patterns are not necessarily comparable treatment evidence, and per-answer source links remain unverified.

Limits agency when

Transcript editing, source links, aggregate-use refusal and third-party processing specifics remain unresolved

Patient agency assessment

Who sets and changes the goal?

Patient authority

Patients initiate recording and questions and can reuse summaries. The public pass does not establish editable transcripts or control over all cohort-derived uses.

What can the patient understand, question, or do?

Critical capacity

A retained visit account can support questions and challenge misunderstandings. Cohort patterns are not necessarily comparable treatment evidence, and per-answer source links remain unverified.

Can the patient evaluate the conditions of use?

Informed control

The FAQ's blanket no-individual-sharing language needs the policy's explicit optional sharing exception. Sponsor non-influence is a vendor statement, not independently verified neutrality.

Text findings

Conditions of use

Published controls and their limits

The FAQ's blanket no-individual-sharing language needs the policy's explicit optional sharing exception. Sponsor non-influence is a vendor statement, not independently verified neutrality.

What remains unknown?

Not tested or not established

Transcript editing, source links, aggregate-use refusal and third-party processing specifics remain unresolved

Who evaluated this?

AI-assisted public-source draft

Vendor statements describe published conditions, not independently verified behavior. No clinical, security, accessibility, or legal validation is claimed. Earlier evidence remains dated in the report and history.

Sources checked

Source-specific findings and retrieval limitations are recorded in the full report.

Earlier review provenance

Criteria

CAIHL-derived HugoScore framework and September 7 qualitative review priorities. Draft v1.2 numerical anchors remain unadopted.

Reviewer

AI-assisted public-source reassessment prepared in OpenAI Codex.

AI / model

OpenAI Codex / GPT-6

Human review

Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.

Review date

2026-09-08

Limitations

Transcript editing, source links, aggregate-use refusal and third-party processing specifics remain unresolved No live product use, patient-data upload, account creation, code audit, clinical evaluation, or independent implementation validation.

Earlier review method

Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.

Document-based draft · Moderate for public product and policy descriptions (AI-assisted draft)